GVR Report cover Pharmaceutical Glass Packaging Market Size, Share & Trends Report

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Material (Type I, Type II, Type III), By Product (Vials, Bottles, Ampoules), By Drug Type (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-175-7
  • Number of Pages: 165
  • Format: Electronic (PDF)

Market Size & Trends

The global pharmaceutical glass packaging market size was estimated at USD 19.75 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030. Extensive utilization of generic injectable drugs coupled with high demand from the pharmaceutical industry is anticipated to drive market growth. Limestone (CaCO3), soda ash (Na2CO3), cullet, and sand (SiO2) comprise the overall chemical composition of glass. For pharmaceutical packaging applications, the most common cations found in glassware are barium, zinc, ferrous, magnesium, calcium, potassium, sodium, boron, aluminum, and silicon. These materials influence the properties of glass such as chemical resistance, hardness, and durability.

U.S. pharmaceutical glass packaging market size, by product, 2020 - 2030 (USD Billion)

According to the U.S. Centers for Medicare & Medicaid Services, the national health spending of the country is expected to grow at an annual rate of 5.4% and expected to reach USD 6.2 trillion by 2028. The federal government healthcare expenditure supporting programs such as the Veterans Administration, U.S. Department of Defense healthcare programs, Affordable Care Act (ACA), Children’s Health Insurance Program (CHIP), Medicaid, and Medicare are expected to support the healthcare-related aid to the U.S. population can increase the consumption for pharmaceuticals, thereby positively impacting the market in the country.

The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to the drug delivery products. Multiple manufacturers working in pharmaceutical glass manufacturing market are focused on packaging aimed at increasing shelf life of a product and are therefore investing in vials.

Pharmaceutical glass packaging developers have been enhancing their product capabilities in order to cater to the changing pharmaceutical industry, which can further contribute to the market in the U.S. For instance, in November 2023, Corning Incorporated introduced coated specially engineered Type I borosilicate vials known as Corning Velocity Vials. These vials exhibit effective hardness compared to conventional borosilicate vials, reducing the probability of cracking and breaking.

The additional impact of COVID-19 pandemic has left the pharmaceutical industry with a steadily growing high demand for medicines and other healthcare facilities. The surge in demand for pharmaceutical drugs, as a result of the pandemic, has affected the market positively. The demand is expected to reach a new peak in the case of approval for COVID-19 vaccines developed by different institutions and companies in various countries.

For instance, the U.S. produces millions of surplus doses of vaccines that are packaged in large, multi-dose vials. These vials are either used domestically or distributed to other countries of the world. The U.S. is expected to have approximately 500 million doses of the Johnson & Johnson, Moderna, and Pfizer-BioNTech vaccines by 2022 Despite the demand from state officials in U.S., there have been various challenges for manufacturers in switching from large multi-dose vials to single-dose vials for supplying vaccines.

Presently, most vaccines in the U.S. are distributed in the form of single-dose vials or prefilled syringes, but the COVID-19 vaccines are being distributed through multi-dose vials owing to the requirement of their quick manufacturing in the early months of the inoculation campaign carried out in the country.

Glass poses as a hindrance to atmospheric gases such as carbon dioxide and oxygen from entering the primary pharmaceutical glass container, mitigating the risk of contamination of the drugs. Glass packaging lowers the drug’s susceptibility to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in near future.

The Pharmaceutical Glass Packaging Market is poised for significant growth and innovation. Given its recyclable nature, the industry's increasing focus on sustainability and environmentally friendly packaging solutions positions glass as an attractive choice, which aligns well with pharmaceutical companies' heightened emphasis on sustainable practices. Integrating intelligent packaging technologies, such as RFID tags and tamper-evident features, enhances the appeal and functionality of pharmaceutical glass packaging. In response to tightening regulations on pharmaceutical packaging, manufacturers that offer inventive, compliant, and cost-effective glass packaging solutions are well-positioned to capture substantial market share.

Market Concentration & Characteristics

Pharmaceutical glass packaging market is witnessing growth owing to high product demand in pharmaceutical industry and extensive utilization of glass in generic injectable drugs. The glass used for primary pharmaceutical packaging has a well-established production system and supply chain. A large number of suppliers are mainly concentrated in the developed regions, such as North America and Europe, owing to the presence of a well-established pharmaceutical industry here.

Pharmaceutical Glass Packaging Market Concentration & Characteristics

Key players in the market include Gerresheimer AG, Corning Incorporated, Nipro Corporation, Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co., Ltd., Bormioli Rocco Pharma, Ardagh Group, West Pharmaceutical Services, Inc., Şişecam Group, Stölzle Oberglas GmbH, and Beatson Clark. In terms of revenue, the top ten manufacturers in the market hold a share of over 75.0%, while the other manufacturers account for the rest.

Companies such as Gerresheimer AG, Corning Incorporated, and Schott AG are pioneers of a majority of the research initiatives undertaken in pharmaceutical glass packaging market. These companies are engaged in introducing new technologies and products to better cater to drug manufacturing companies across the globe. An increasing number of innovative biotech drugs, which have to be injected, are being introduced in the market and must be supplied in the necessary concentrations in vials and prefilled syringes.

Manufacturers of glass packaging for pharmaceuticals are constantly striving to offer a wide range of technologies covering as much of the value chain as possible. For instance, On July 13, 2023, Corning Inc. launched the innovation in the pharmaceutical glass packaging portfolio “Viridian Vials”. The new technology can improve filling-line efficiency by up to 50% while reducing vial-manufacturing carbon dioxide equivalent emissions by up to 30%. These new product uses 20% less glass material than conventional glass vials, with no impact on the quality or safety of the vial. This reduction in glass material lowers manufacturing and transportation-related emissions by up to 30% and decreases the total amount of glass entering the waste stream. Viridian’s low-friction external coating minimizes cracks, breaks, and cosmetic rejects while improving filling-line efficiency by up to 50%.

Material Insights

Based on material, market is segmented into the Type I, Type II, and Type III.

Type I Glass (Borosilicate Glass) is accounted for the major share of the market in 2023, and it is anticipated that it will maintain its attractiveness during the forecast period. As the glass has exceptional resistance to chemical interactions. It is commonly used for parenteral drug products, injectables, and other formulations that demand a high level of chemical durability and stability.

Pharmaceutical glass type II is soda-lime glass treated to enhance its chemical resistance. While not as inert as Type I, it still provides a suitable barrier for many pharmaceutical products.

Product Insights

Pharmaceutical glass bottles were the largest market segment, accounting for more than 34.2% in 2023 in terms of global revenue. The pharmaceutical glass packaging market has been segmented on the basis of product as ampoules, bottles, vials, syringes, and cartridges. Vials have high analytical performance and great sustainability, which is expected to drive the segment with second fastest growth rate after ampoules. Therefore, the vials segment is expected to witness a rise in market share over the forecast period from 33.3% in 2023.

Pharmaceutical glass vials are made from Type 1 borosilicate glass which imparts the desired chemical resistance properties to the glass vials. Ampoules is expected to witness the fastest growth, whereas the largest market share is anticipated to be held by bottles. It also accounted for a volume share of over 75.0% in 2023 owing to its better analytical performance and suitability.

Glass bottles used for pharmaceutical packaging are categorized into two types depending on their size, namely, small bottles and large bottles. The large size glass bottles are used for packaging of reagents as well as transfusion and infusion bottles.  The small glass bottles is used for packaging of syrup bottles and other oral liquids. The small-sized sized bottles segment is expected to witness growth on account of numerous new opportunities including the rising consumption of oral tablets that are packaged in small bottles.

Ampoules that are largely developed from glass are anticipated to grow with the most attractive CAGR, in terms of revenue, during the forecast period from 2024 to 2030 owing to the ability of glass to filter specific wavelengths, high microbiological control, and high chemical resistance. Large number of ampoules are produced in compliance with the DIN ISO EN 9187-1/2 standard in sealed designs, funnel-type, and straight-stem.

Drug Type Insights

Generic drug type led the market and accounted for more than 72.9% share of the global revenue in 2023. The global market for generic drugs has seen a rise in the past several years due to increasing cases of chronic diseases, aging population, and the rise in the expiration of drug patents.

Furthermore, the efforts from governments and healthcare service providers to reduce healthcare expenditure & drug prices and provision of health insurance coverage are also anticipated to fuel the consumption of generic drugs. The increased consumption of generics is expected to ascend the demand for pharmaceutical glass packaging owing to its regulatory ease and extraordinary barrier property.

Global pharmaceutical glass packaging market share, by drug type, 2022 (%)

The growth of biologic drugs is majorly due to their ability to treat major chronic diseases, especially certain forms of autoimmune diseases and cancer. However, glass delamination and chipping that results from surface degradation is anticipated to lower the growth of primary glass packaging for the biologic drugs.

The generic drug segment in North America is expected to witness a higher growth than branded segment, both in terms of volume and revenue, as it is affordable, whereas the patent expirations are going to further led the branded segment to have a moderate growth rate. The primary glass packaging is expected to show a sluggish growth on account of decreased volume sales of branded drugs.

The pharmaceutical industry is expected to largely benefit from biologics as they cater to therapeutic aspects that are underserved. The biosimilar competition for biologics has remained low resulting in moderate growth of the segment, thereby slowing the growth of the segment in the market.

The U.S. boasts presence of pharmaceutical giants and therefore is expected to stay a core region for various business activities related to pharmaceutical glass packaging. The customer consolidation and increased competitive intensity in the country is expected to result in a significant increase in the volume of generic drug sales causing rapid change in market dynamics. This change coupled with patent expirations of numerous drugs is expected to constrain branded product sales in the U.S.

Regional Insights

North America dominated the market and accounted for more than 35.5% share of global revenue in 2023. The developing markets are expected to witness a surge in spending in the pharmaceutical industry over the upcoming years. The U.S. is expected to remain a key driver and most important market for the growth of the pharmaceutical sector in the region with innovative products leading the growth. This growth is expected to be aided by the rise in generics in the region that are anticipated to witness consistently high demand in terms of volume and sales.

Emerging markets are expected to show higher growth rates compared to developed markets due to the rapid increase in consumer base and spending. Increased cases of chronic ailments, increased healthcare awareness, and rising income levels are expected to further aid the growth of emerging markets in the Asia Pacific. The governments in the Asia Pacific region are expanding their private and public healthcare coverage as a result of increased awareness. The efforts of the government in developing regions to promote low-cost generic drugs and reduce healthcare costs is expected to result in an increased volume of pharmaceutical products further fueling the growth of the market in the region.

Pharmaceutical Glass Packaging Market Trends by Region

Europe region accounted for more than 19.0% of the volume share in 2023. The research-based pharmaceutical industry is a key asset of the European economy. The pharmaceutical glass packaging industry is on the rise owing to the growth in medical progress by means of research, development, and introduction of new medicines aimed at improving the health and quality of life of patients in the region.

The national regulation that holds down prices & profits and results in market fragmentation is anticipated to be a major factor that differentiates the strengths of the European research-based industry and its American counterparts in the pharmaceutical sector.

The current Russia and Ukraine conflict has negatively impacted the energy supplies consisting of natural gas and electricity, thereby progressing its impact on the glass production in the Europe. Since glass manufacturing involves melting of limestone, soda ash, and sand, the temperatures required for melting the mixture depend on the energy generated from the natural gas supplied by Russia. The natural gas shortage has led to the halting of operations by European bottle manufacturers, automobile manufacturers, and skyscraper builders.

Asia Pacific is anticipated to be the fastest-growing region in terms of revenue. This growth in demand can be ascertained by the presence of numerous small and medium scaled production units in the region. The region also enjoys lenient regulatory regimes which work out to support the manufacturers, along with attracting foreign investment. Usually, companies like Corning Incorporated and Schott AG partners up with small scaled production units in the region which provides them a platform to expand their regional presence along with gaining higher market share.

Saudi Arabia Pharmaceutical Glass Packaging Market:

International pharmaceutical players' rising interest in setting up their offices to capture the attractive markets in the Middle East & North Africa is further expected to impact the market growth positively. The Saudi Arabian pharmaceutical market reach to USD 10.74 billion in 2023, according to the Ministry of Health and Prevention (MoHaP). In an event, the Ministry of Health and Prevention (MoHaP) laid out the kingdom's planning of rapid reforms in the field of healthcare at both service provision and regulatory levels, which is in line with the National Transformation Program and Saudi Arabia's Vision 2030.

Key Companies & Market Share Insights

Numerous pharmaceutical glass manufacturing companies are primarily concentrated in the developed regions such as Europe and North America resulting in well-established supply chain and production system in the regions. However, manufacturers are shifting their base to countries such as Brazil, India, and China due to low labor costs and growth of opportunities offered by these countries. The generic sector is expected to drive the demand for pharmaceutical glass packaging in these countries over the forecast period.

  • In June 2023, Müller + Müller, the manufacturer of primary packaging materials made of tubular glass for the pharmaceutical industry, has invested 15 million EUR at its vial manufacturing site in Holzminden. The investment includes up to 14 new production lines as well as a corresponding clean room.

  • In June 2023, Corning and SGD Pharma with joint venture open a new glass tubing facility and expand access to Corning Velocity Vial technology in in Telangana, India. Manufacturing of Velocity Vials at SGD Pharma’s facility in Vemula, India, is expected to begin in 2024. Pharmaceutical tubing production is expected to begin in 2025.

Key Pharmaceutical Glass Packaging Companies:

  • Corning Incorporated
  • Nipro Corporation
  • SGD S.A.
  • Stoelzle Oberglas GmbH
  • Bormioli Pharma S.p.A.
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • Shandong Medicinal Glass Co., Ltd.
  • Beatson Clark
  • Ardagh Group S.A
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Şişecam Group
  • Owens-Illinois, Inc.
  • DWK Life sciences

Recent Developments

  • In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG’s expertise with Corning’s glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.

  • In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop new innovation and ideas about pharmaceutical packaging by focusing on augment reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.

  • In March 2023, Schott AG launched the production of FIOLAX®amber pharma glass in India with the aim to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.

  • In October 2022, Gerresheimer AG in collaboration with Merck developed a digitalized twin solution to ensure trust and traceability in the pharmaceutical supply chain. This solution aimed to create a digital representation of packaging for syringes and vials.

  • In January 2022, West Pharmaceutical Services Inc. partnered with Corning to make advancements in drug delivery and drug containment by developing pharmaceutical packaging solutions.

  • In May 2021, Nipro Corporation acquired all shares of Piramida d.o.o to make expansion in the European market, and strengthen its position in the pharmaceutical glass packaging sector.

Pharmaceutical Glass Packaging Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 21.46 billion

Revenue forecast in 2030

USD 37.62 billion

Growth rate

CAGR of 9.8% from 2024 to 2030

Historical data

2018 - 2023

Forecast period

2024 - 2030

Quantitative units

Volume in million units; revenue in USD million/billion, and CAGR from 2024 to 2030

Report coverage

Volume forecast, revenue forecast, competitive landscape, growth factors and trends

Segments covered

Material, product, drug type, region

Regional scope

North America; Europe; Asia Pacific; Central & South America; Middle East & Africa

Country Scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Switzerland; Denmark; Belgium; China; India; Japan; South Korea; Australia; Southeast Asia; Brazil; Argentina; Saudi Arabia; UAE; and South Africa

Key companies profiled

Amcor plc; Becton, Dickinson, and Company; AptarGroup, Inc.; Drug Plastics Group; Gerresheimer AG; Schott AG; Owens Illinois, Inc.; West Pharmaceutical Services, Inc.; Berry Global, Inc.; WestRock Company; SGD Pharma; International Paper; Comar, LLC; CCL Industries, Inc.; Vetter Pharma International

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Pharmaceutical Glass Packaging Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the pharmaceutical glass packaging market report on the basis of material, product, drug type, and region:

Global Pharmaceutical Glass Packaging Market  Segmentation

  • Material Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • Type I

    • Type II

    • Type III

  • Product Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • Vials

      • Small vials

      • Large vials

    • Bottles

      • Small bottles

      • Large bottles

    • Cartridges & Syringes

    • Ampoules

  • Drug Type Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • Generic

    • Branded

    • Biologic

  • Regional Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Switzerland

      • Belgium

      • Denmark

    • Asia Pacific

      • China

      • India

      • Japan

      • South Korea

      • Australia

      • Southeast Asia

    • Central & South America

      • Brazil

      • Argentina

    • Middle East & Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

Table of Contents

Chapter 1. Pharmaceutical Glass Packaging Market: Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definition
                    1.3. Information Procurement
                        1.3.1. Purchased Database
                        1.3.2. GVR’s Internal Database
                        1.3.3. Secondary Sources & Third-Party Perspectives
                        1.3.4. Primary Research
                    1.4. Information Analysis
                        1.4.1. Data Analysis Models
                    1.5. Market Formulation & Data Visualization
                    1.6. Data Validation & Publishing
                    1.7. List of Abbreviations
Chapter 2. Pharmaceutical Glass Packaging Market: Executive Summary
                    2.1. Market Outlook, 2023 (USD Million)
                    2.2. Segmental Outlook
                        2.2.1. Material Outlook
                        2.2.2. Product Outlook
                        2.2.3. Drug Type Outlook
                    2.3. Competitive Landscape Snapshot
Chapter 3. Pharmaceutical Glass Packaging Market: Variables, Trends, and Scope
                    3.1. Market Lineage Outlook
                    3.2. Industry Value Chain Analysis
                        3.2.1. Raw Material Trends
                            3.2.1.1. Type 1 - Borosilicate Glass
                            3.2.1.2. Boric Oxide
                            3.2.1.3. Type II Treated Soda Lime
                            3.2.1.4. Type III Regular Soda Lime
                        3.2.2. Manufacturing Trends
                        3.2.3. Profit Margin Analysis
                        3.2.4. Sales Channel Analysis
                    3.3. Technology Trends / Timeline
                    3.4. Regulatory Framework
                        3.4.1. Standard & Compliance
                        3.4.2. Safety
                    3.5. Market Dynamics
                        3.5.1. Market Driver Analysis
                        3.5.2. Market Restraint Analysis
                        3.5.3. Market Challenges Analysis
                        3.5.4. Market Opportunity Analysis
                    3.6. Business Environment Analysis
                        3.6.1. Industry Analysis - Porter’s
                            3.6.1.1. Supplier Power
                            3.6.1.2. Buyer Power
                            3.6.1.3. Substitution Threat
                            3.6.1.4. Threat from New Entrant
                            3.6.1.5. Competitive Rivalry
                        3.6.2. PESTEL Analysis
                            3.6.2.1. Political Landscape
                            3.6.2.2. Environmental Landscape
                            3.6.2.3. Social Landscape
                            3.6.2.4. Technology Landscape
                            3.6.2.5. Economic Landscape
                            3.6.2.6. Legal Landscape
                        3.6.3. Market Entry Strategies
                    3.7. Unmet Needs & Challenges in Pharmaceutical Glass Packaging Industry
                    3.8. Impact of Environmental, Social, and Governance (ESG) initiatives on the Pharmaceutical Glass Packaging Market
                        3.8.1. Market Differentiation
                        3.8.2. Regulatory Compliance
                        3.8.3. Industry Collaboration
                        3.8.4. Enhanced Brand Value
                        3.8.5. Addressing Consumer Demands
                    3.9. Impact 0f Covid-19 Pandemic on the Pharmaceutical Glass Packaging Market
Chapter 4. Pharmaceutical Glass Packaging Market: Market Supplier Intelligence
                    4.1. Kraljic Matrix (Portfolio Analysis)
                        4.1.1. Non-Critical Items
                        4.1.2. Leverage Items
                        4.1.3. Bottleneck Items
                        4.1.4. Strategic Items
                    4.2. Engagement Model
                    4.3. Negotiation Strategies
                    4.4. Sourcing Best Practices
                    4.5. Vendor Selection Criteria
Chapter 5. Pharmaceutical Glass Packaging Market: Price Trend Analysis
                    5.1. Pricing Trend Analysis, by Material, 2018 - 2030 (USD/Units)
                    5.2. Factors Affecting the Pricing Deviation
Chapter 6. Pharmaceutical Glass Packaging Market: Material Estimates & Trend Analysis
                    6.1. Definition & Scope
                    6.2. Material Movement Analysis & Market Share, 2023 & 2030
                    6.3. Type I
                        6.3.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    6.4. Type II
                        6.4.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    6.5. Type III
                        6.5.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Chapter 7. Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis
                    7.1. Definition & Scope
                    7.2. Product Movement Analysis & Market Share, 2023 & 2030
                    7.3. Vials
                        7.3.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    7.4. Bottles
                        7.4.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    7.5. Cartridges & Syringes
                        7.5.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    7.6. Ampoules
                        7.6.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Chapter 8. Pharmaceutical Glass Packaging Market: Drug Type Estimates & Trend Analysis
                    8.1. Definition & Scope
                    8.2. Drug Type Movement Analysis & Market Share, 2023 & 2030
                    8.3. Generic
                        8.3.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    8.4. Branded
                        8.4.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
                    8.5. Biologic
                        8.5.1. market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Chapter 9. Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis
                    9.1. Key Takeaways
                    9.2. Regional Movement Analysis & Market Share, 2023 & 2030
                    9.3. North America
                        9.3.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                        9.3.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                        9.3.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                        9.3.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.3.5. U.S.
                            9.3.5.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.3.5.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.3.5.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.3.5.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.3.6. Canada
                            9.3.6.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.3.6.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.3.6.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.3.6.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.3.7. Mexico
                            9.3.7.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.3.7.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.3.7.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.3.7.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                    9.4. Europe
                        9.4.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                        9.4.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                        9.4.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                        9.4.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.4.5. Germany
                            9.4.5.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.5.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.5.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.5.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                                9.4.6. U.K.
                            9.4.6.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.6.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.6.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.6.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.4.7. Italy
                            9.4.7.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.7.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.7.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.7.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.4.8. Spain
                            9.4.8.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.8.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.8.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.8.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.4.9. Switzerland
                            9.4.9.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.9.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.9.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.9.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.4.10. Denmark
                            9.4.10.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.10.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.10.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.10.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.4.11. Belgium
                            9.4.11.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.4.11.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.4.11.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.4.11.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                    9.5. Asia Pacific
                        9.5.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                        9.5.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                        9.5.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                        9.5.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.5.5. China
                            9.5.5.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.5.5.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.5.5.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.5.5.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.5.6. India
                            9.5.6.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.5.6.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.5.6.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.5.6.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.5.7. Japan
                            9.5.7.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.5.7.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.5.7.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.5.7.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.5.8. South Korea
                            9.5.8.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.5.8.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.5.8.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.5.8.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.5.9. Australia
                            9.5.9.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.5.9.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.5.9.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.5.9.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.5.10. Southeast Asia
                            9.5.10.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.5.10.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.5.10.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.5.10.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                    9.6. Central & South America
                        9.6.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                        9.6.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                        9.6.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                        9.6.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.6.5. Brazil
                            9.6.5.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.6.5.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.6.5.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.6.5.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.6.6. Argentina
                            9.6.6.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.6.6.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.6.6.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.6.6.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                    9.7. Middle East & Africa
                        9.7.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                        9.7.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                        9.7.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                        9.7.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.7.5. Saudi Arabia
                            9.7.5.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.7.5.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.7.5.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.7.5.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.7.6. UAE
                            9.7.6.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.7.6.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.7.6.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.7.6.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
                        9.7.7. South Africa
                            9.7.7.1. market estimates and forecasts, 2018 - 2030 (USD million) (Million Units)
                            9.7.7.2. market estimates and forecasts, by material, 2018 - 2030 (Million Units) (USD Million)
                            9.7.7.3. market estimates and forecasts, by product, 2018 - 2030 (Million Units) (USD Million)
                            9.7.7.4. market estimates and forecasts, by drug type, 2018 - 2030 (Million Units) (USD Million)
Chapter 10. Start-up Ecosystem Evaluation, 2023
                    10.1. List of Start-up Companies
                        10.1.1. Progressive Companies
                        10.1.2. Responsive Companies
                        10.1.3. Dynamic Companies
                        10.1.4. Starting Blocks
                    10.2. Government Funding for Start-ups across the globe
Chapter 11. Competitive Landscape
                    11.1. Key Global Players & Recent Developments & Their Impact On the Industry
                    11.2. Key Company/Competition Categorization (Key innovators, Market leaders, emerging players)
                    11.3. List of key Raw Material Distributors and Channel Partners
                    11.4. List of Potential Customers, by End-use
                    11.5. Company Market Share & Position Analysis, 2023
                    11.6. Company Heat Map Analysis
                    11.7. Competitive Dashboard Analysis
                    11.8. Strategy Mapping
                        11.8.1. Capacity Expansion
                        11.8.2. Collaboration/ Partnerships/ Agreements
                        11.8.3. New Product launches
                        11.8.4. Mergers & Acquisitions
                        11.8.5. Innovation in Technology/ Material
                        11.8.6. Others
Chapter 12. Company Listing / Profiles
                    12.1. Corning Incorporated
                        12.1.1. Company Overview
                        12.1.2. Financial Performance
                        12.1.3. Product Benchmarking
                    12.2. Nipro Corporation
                        12.2.1. Company Overview
                        12.2.2. Financial Performance
                        12.2.3. Product Benchmarking
                    12.3. SGD S.A.
                        12.3.1. Company Overview
                        12.3.2. Financial Performance
                        12.3.3. Product Benchmarking
                    12.4. Stölzle-Oberglas GmbH
                        12.4.1. Company Overview
                        12.4.2. Financial Performance
                        12.4.3. Product Benchmarking
                    12.5. West Pharmaceutical Services, Inc.
                        12.5.1. Company Overview
                        12.5.2. Financial Performance
                        12.5.3. Product Benchmarking
                    12.6. Schott AG
                        12.6.1. Company Overview
                        12.6.2. Financial Performance
                        12.6.3. Product Benchmarking
                    12.7. Gerresheimer AG
                        12.7.1. Company Overview
                        12.7.2. Financial Performance
                        12.7.3. Product Benchmarking
                    12.8. Bormioli Pharma S.r.l
                        12.8.1. Company Overview
                        12.8.2. Financial Performance
                        12.8.3. Product Benchmarking
                    12.9. Shandong Medicinal Glass Co., Ltd.
                        12.9.1. Company Overview
                        12.9.2. Financial Performance
                        12.9.3. Product Benchmarking
                    12.10. Beatson Clark
                        12.10.1. Company Overview
                        12.10.2. Financial Performance
                        12.10.3. Product Benchmarking
                    12.11. Ardagh Group S.A.
                        12.11.1. Company Overview
                        12.11.2. Financial Performance
                        12.11.3. Product Benchmarking
                    12.12. Arab Pharmaceutical Glass Co.
                        12.12.1. Company Overview
                        12.12.2. Financial Performance
                        12.12.3. Product Benchmarking
                    12.13. Piramal Enterprises Ltd.
                        12.13.1. Company Overview
                        12.13.2. Financial Performance
                        12.13.3. Product Benchmarking
                    12.14. Şişecam Group
                        12.14.1. Company Overview
                        12.14.2. Financial Performance
                        12.14.3. Product Benchmarking
                    12.15. Owens-Illinois, Inc
                        12.15.1. Company Overview
                        12.15.2. Financial Performance
                        12.15.3. Product Benchmarking
                    12.16. DWK Life Sciences
                        12.16.1. Company Overview
                        12.16.2. Financial Performance
                        12.16.3. Product Benchmarking


List of Tables

Table 1 Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 2 Type I Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 3 Type II Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 4 Type III Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 5 Pharmaceutical Glass Packaging Market estimates and forecasts, by vials, 2018 - 2030 (USD Million) (Million Units)
Table 6 Pharmaceutical Glass Packaging Market estimates and forecasts, by bottles, 2018 - 2030 (USD Million) (Million Units)
Table 7 Tertiary Pharmaceutical Glass Packaging Market estimates and forecasts, by cartridges & syringes, 2018 - 2030 (USD Million) (Million Units)
Table 8 Pharmaceutical Glass Packaging Market estimates and forecasts, by ampoules, 2018 - 2030 (USD Million) (Million Units)
Table 9 Pharmaceutical Glass Packaging Market estimates and forecasts, in generic, 2018 - 2030 (USD Million) (Million Units)
Table 10 Pharmaceutical Glass Packaging Market estimates and forecasts, in branded, 2018 - 2030 (USD Million) (Million Units)
Table 11 Pharmaceutical Glass Packaging Market estimates and forecasts, in biologic, 2018 - 2030 (USD Million) (Million Units)
Table 12 North America Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 13 North America Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 14 North America Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 15 North America Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 16 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 17 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 18 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 19 U.S. Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 20 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 21 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 22 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 23 Canada Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug Type, 2018 - 2030 (USD Million) (Million Units)
Table 24 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 25 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million)
Table 26 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (Million Units)
Table 27 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 28 Mexico Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug Type, 2018 - 2030 (USD Million)
Table 29 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 30 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 31 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 32 Europe Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million)
Table 33 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 34 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 35 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 36 Germany Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million) (Million Units)
Table 37 UK Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 38 UK Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 39 UK Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 40 UK Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million)
Table 41 France Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 42 France Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 43 France Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 44 France Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million) (Million Units)
Table 45 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 46 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 47 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 48 Italy Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million) (Million Units)
Table 49 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 50 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 51 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 52 Spain Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million) (Million Units)
Table 53 Switzerland Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 54 Switzerland Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million)
Table 55 Switzerland Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 56 Switzerland Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million)
Table 57 Denmark Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 58 Denmark Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 59 Denmark Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 60 Denmark Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million) (Million Units)
Table 61 Belgium Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 62 Belgium Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 63 Belgium Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 64 Belgium Pharmaceutical Glass Packaging Market estimates and forecasts, by Drug type, 2018 - 2030 (USD Million) (Million Units)
Table 65 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 66 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 67 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 68 Asia Pacific Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 69 China Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 70 China Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (Million Units) (Million Units)
Table 71 China Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 72 China Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 73 India Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 74 India Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 75 India Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 76 India Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 77 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 78 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 79 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 80 Japan Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 81 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 82 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 83 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 84 South Korea Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 85 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 86 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 87 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 88 Australia Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 89 Southeast Asia Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 90 Southeast Asia Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 91 Southeast Asia Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 92 Southeast Asia Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 93 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 94 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 95 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 96 Central & South America Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 97 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 98 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 99 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 100 Brazil Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 101 Argentina Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 102 Argentina Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 103 Argentina Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 104 Argentina Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 105 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 106 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 107 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 108 Middle East & Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 109 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 110 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 111 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 112 Saudi Arabia Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 113 UAE Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 114 UAE Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 115 UAE Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 116 UAE Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)
Table 117 South Africa Pharmaceutical Glass Packaging Market estimates and forecasts, 2018 - 2030 (USD Million) (Million Units)
Table 118 South Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by material, 2018 - 2030 (USD Million) (Million Units)
Table 119 South Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Million Units)
Table 120 South Africa Pharmaceutical Glass Packaging Market estimates and forecasts, by drug type, 2018 - 2030 (USD Million) (Million Units)


List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Primary Research Process
Fig. 4 Market research approaches - Bottom-Up Approach
Fig. 5 Market research approaches - Top-Down Approach
Fig. 6 Market research approaches - Combined Approach
Fig. 7 Pharmaceutical Glass Packaging Market- Market Snapshot
Fig. 8 Pharmaceutical Glass Packaging Market- Segment Snapshot (1/2)
Fig. 9 Pharmaceutical Glass Packaging Market- Segment Snapshot (2/2)
Fig. 10 Pharmaceutical Glass Packaging Market- Competitive Landscape Snapshot
Fig. 11 Pharmaceutical Glass Packaging Market: Penetration & Growth Prospect Mapping
Fig. 12 Pharmaceutical Glass Packaging Market: Value Chain Analysis
Fig. 13 Pharmaceutical Glass Packaging Market: Porter’s Five Force Analysis
Fig. 14 Pharmaceutical Glass Packaging Market: PESTEL Analysis
Fig. 15 Pharmaceutical Glass Packaging market: Material movement analysis, 2023 & 2030
Fig. 16 Pharmaceutical Glass Packaging market: Product movement analysis, 2023 & 2030
Fig. 17 Pharmaceutical Glass Packaging market: Drug type movement analysis, 2023 & 2030
Fig. 18 Pharmaceutical Glass Packaging market: Regional movement analysis, 2023 & 2030
Fig. 19 Pharmaceutical Glass Packaging Market: Competitive Dashboard Analysis

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Market Segmentation

  • Material Outlook (Volume, Million Units; Revenue, USD Million; 2018 - 2030)
    • Type I
    • Type II
    • Type III
  • Product Outlook (Volume, Million Units; Revenue, USD Million; 2018 - 2030)
    • Vials
    • Small Vials
    • Large Vials
    • Bottles
    • Small Vials
    • Large Vials
    • Cartridges & Syringes
    • Ampoules
  • Drug Type Outlook (Volume, Million Units; Revenue, USD Million; 2018 - 2030)
    • Generic
    • Branded
    • Biologic
  • Regional Outlook (Volume, Million Units; Revenue, USD Million; 2018 - 2030)
    • North America
      • North America Pharmaceutical Glass Packaging Market, By Material
        • Type I
        • Type II
        • Type III
      • North America Pharmaceutical Glass Packaging Market, By Product
        • Vials
        • Small Vials
        • Large Vials
        • Bottles
        • Small bottles
        • Large bottles
        • Cartridges & Syringes
        • Ampoules
      • North America Pharmaceutical Glass Packaging Market, By Drug Type
        • Generic
        • Branded
        • Biologic
      • U.S.
        • U.S. Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • U.S. Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • U.S. Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Canada
        • Canada Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Canada Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Canada Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Mexico
        • Mexico Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Mexico Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Mexico Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
    • Europe
      • Europe Pharmaceutical Glass Packaging Market, By Material
        • Type I
        • Type II
        • Type III
      • Europe Pharmaceutical Glass Packaging Market, By Product
        • Vials
        • Small Vials
        • Large Vials
        • Bottles
        • Small bottles
        • Large bottles
        • Cartridges & Syringes
        • Ampoules
      • Europe Pharmaceutical Glass Packaging Market, By Drug Type
        • Generic
        • Branded
        • Biologic
      • UK
        • UK Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • UK Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • UK Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Germany
        • Germany Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Germany Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Germany Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • France
        • France Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • France Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • France Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Italy
        • Italy Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Italy Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Italy Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Spain
        • Spain Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Spain Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Spain Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Switzerland
        • Switzerland Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Switzerland Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Switzerland Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Belgium
        • Belgium Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Belgium Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Belgium Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Denmark
        • Denmark Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Denmark Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Denmark Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
    • Asia Pacific
      • Asia Pacific Pharmaceutical Glass Packaging Market, By Material
        • Type I
        • Type II
        • Type III
      • Asia Pacific Pharmaceutical Glass Packaging Market, By Product
        • Vials
        • Small Vials
        • Large Vials
        • Bottles
        • Small bottles
        • Large bottles
        • Cartridges & Syringes
        • Ampoules
      • Asia Pacific Pharmaceutical Glass Packaging Market, By Drug Type
        • Generic
        • Branded
        • Biologic
      • China
        • China Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • China Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • China Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Japan
        • Japan Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Japan Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Japan Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • India
        • India Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • India Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • India Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • South Korea
        • South Korea Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • South Korea Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • South Korea Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Australia
        • Australia Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Australia Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Australia Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Southeast Asia
        • Southeast Asia Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Southeast Asia Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Southeast Asia Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
    • Central & South America
      • Central & South America Pharmaceutical Glass Packaging Market, By Material
        • Type I
        • Type II
        • Type III
      • Central & South America Pharmaceutical Glass Packaging Market, By Product
        • Vials
        • Small Vials
        • Large Vials
        • Bottles
        • Small Bottles
        • Large Bottles
        • Cartridges & Syringes
        • Ampoules
      • Central & South America Pharmaceutical Glass Packaging Market, By Drug Type
        • Generic
        • Branded
        • Biologic
      • Brazil
        • Brazil Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Brazil Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Brazil Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • Argentina
        • Argentina Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Argentina Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Argentina Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
    • Middle East & Africa
      • Middle East & Africa Pharmaceutical Glass Packaging Market, By Material
        • Type I
        • Type II
        • Type III
      • Middle East & Africa Pharmaceutical Glass Packaging Market, By Product
        • Vials
        • Small Vials
        • Large Vials
        • Bottles
        • Small Bottles
        • Large Bottles
        • Cartridges & Syringes
        • Ampoules
      • Middle East & Africa Pharmaceutical Glass Packaging Market, By Drug Type
        • Generic
        • Branded
        • Biologic
      • Saudi Arabia
        • Saudi Arabia Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • Saudi Arabia Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • Saudi Arabia Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic
      • United Arab Emirates
        • United Arab Emirates Pharmaceutical Glass Packaging Market, By Material
          • Type I
          • Type II
          • Type III
        • United Arab Emirates Pharmaceutical Glass Packaging Market, By Product
          • Vials
          • Small Vials
          • Large Vials
          • Bottles
          • Small Bottles
          • Large Bottles
          • Cartridges & Syringes
          • Ampoules
        • United Arab Emirates Pharmaceutical Glass Packaging Market, By Drug Type
          • Generic
          • Branded
          • Biologic

Pharmaceutical Glass Packaging Market Dynamics

Driver: Growth of the Pharmaceutical Industry in Emerging Economies

Emerging economies including China, India, and Brazil are providing an outstanding opportunity for the growth of the pharmaceutical industry. These economies showcase a huge market potential in the global pharmaceutical industry. The growing population focus on increasing life expectancy, and increasing disposable income are some of the factors expected to provide companies with attractive opportunities in the coming years as several companies are struggling with the stagnation of mature markets, expiration of patents, and a rise in regulatory hurdles. The healthcare infrastructure in the abovementioned economies has observed a drastic change and therefore, the one-size-fits-all approach cannot be applied to emerging markets. Even among the three main market clusters - the BRICMT economies, namely Brazil, Russia, India, China, Mexico, and Turkey and the second-tier countries in Southeast Asia and Africa — there are local idiosyncrasies that make bespoke approaches to these markets essential.

Driver: Commodity Value of Glass Increased with Recyclability

Glass is 100% recyclable in nature and can be reprocessed limitlessly without loss in quality or purity. The recycled glass can be substituted for up to 95.0% of raw materials such as sand, soda ash, limestone, and cullet (recycled glass). The recycling of glass products aids manufacturers as it decreases the amount of raw material used and helps in reducing emissions. Furthermore, the recycling of glass extends the life of plant equipment such as furnaces and saves energy. According to data published in May 2014 by Glass Packaging Institute, a trade association representing the North American glass container industry, 40.0% of glass beer and soft drink bottles, 32.0% of wine and liquor bottles, 15.0% of food jars, and around 32.5% of all glass containers were recycled in the U.S. This helped the developers of glass containers to save approximately 1,300 pounds of sand, 410.0 pounds of soda ash, 380.0 pounds of limestone, and 160.0 pounds of feldspar.

Restraint: Increased Relevance of Alternate Sources

The market for pharmaceutical glass packaging is projected to observe a slight slump in the forecast period mainly due to the high cost of glass raw materials and unavailability of economically viable solutions for the packaging of products for mass consumption. Plastic bottles used for pharma packaging are made of a special plastic, known as polyethylene terephthalate (PET), which is a clear, strong, and lightweight plastic belonging to the polyester family. It is the same plastic that is globally used for the storage and selling of packaged drinking water, carbonated soft drinks, and soda, among other consumable liquid products. PET is deemed safe for direct contact with food and beverage by health and regulatory agencies globally including the U. S. Food & Drug Administration, Health Canada, and the European Food Safety Authority. Furthermore, the plastic is non-leaching and non-extractable, thereby allowing the formulation to remain unchanged and safe.

What Does This Report Include?

This section will provide insights into the contents included in this pharmaceutical glass packaging market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Pharmaceutical glass packaging market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Pharmaceutical glass packaging market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Research Methodology

A three-pronged approach was followed for deducing the pharmaceutical glass packaging market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for pharmaceutical glass packaging market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of pharmaceutical glass packaging market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Pharmaceutical Glass Packaging Market Categorization:

The pharmaceutical glass packaging market was categorized into four segments, namely material (Type I, II, III), product (Vials, Bottles, Cartridges & Syringes, Ampoules), drug type (Generic, Branded, Biologic), and region (North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa).

Segment Market Methodology:

The pharmaceutical glass packaging market was segmented into material, product, drug type, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The pharmaceutical glass packaging market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-one countries, namely, the U.S.; Canada; Mexico; Germany; the UK; France; Italy; Spain; Switzerland; Denmark; Belgium; China; India; Japan; South Korea; Australia; Southeast Asia; Brazil; Argentina; Saudi Arabia; UAE; and South Africa.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Pharmaceutical glass packaging market companies & financials:

The pharmaceutical glass packaging market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Corning Incorporated: Coring Inc. was established in 1851 and is headquartered in New York, U.S. The company is engaged in the manufacturing of specialty glass and ceramics and its business segments include display technologies, optical communications, environmental technologies, specialty materials, and life sciences, among others. The company has 98 production facilities across 17 countries. Corning Incorporated’s display technologies segment manufactures glass substrates for flat-panel liquid crystal displays (LCDs) and the optical communications segment manufactures carrier and enterprise network components for the telecommunications industry. The company’s environmental technologies segment manufactures ceramic substrates and filters for automotive and diesel emission control applications. Its specialty materials segment offers products that provide more than 150 material formulations for glass, glass ceramics, and fluoride crystals. The life sciences segment of Corning Incorporated manufactures glass and plastic labware, equipment, media, and reagents. Other important sources of revenue for the company are its pharmaceutical technologies business and non-LCD glass business.

  • Nipro Corporation: The company was established in 1948 and is headquartered in Osaka, Japan. The company is involved in the manufacturing, development, and sale of pharmaceutical, medical, and glass products. The company’s product portfolio is classified into four business segments, including medical devices, pharmaceuticals, and pharma packaging, among others. Nipro Corporation’s pharma packaging segment is involved in the manufacturing of glass molding vials, ampoules, syringes, and cartridges; glass-forming machinery; glass tubes for pharmaceuticals; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging including rubber plugs. The segment accounted for 8% of total sales in the year 2019. The Pharma packaging segment of the company has a worldwide manufacturing footprint with around 16 plants across eight countries. As of 2019, the company employed approximately 29,325 personnel globally. Over the coming years, the company plans to increase its focus on the development of advanced products that meet the needs of medical professionals and patients worldwide.

  • SGD S.A.: The company was established in 1955 and is headquartered in Puteaux, France. The company is primarily engaged in manufacturing glass and glassware. It produces over 2 billion vials and bottles per annum in its five manufacturing plants located in Europe and Asia. The company operates through ten sales offices and five manufacturing facilities worldwide. As of December 2019, the company employed over 3,000 personnel globally. SGD S.A. offers a broad range of sizes and finishes in Type I, II, or III, amber, and clear glass; and innovative value-added services like internal siliconization or protective plastic coatings. The company caters to a variety of applications in the pharmaceutical industry, such as injectables, infusions, oral, nasal, and health & beauty care.

  • Stölzle-Oberglas GmbH: The company was established in 1871 and is headquartered in Köflach, Austria. The company manufactures high-end packaging glass containers for pharmaceuticals, perfumery and cosmetics, spirits, and food & beverages sectors. The company has six production sites in Austria, Great Britain, France, the Czech Republic, and Poland. Moreover, it has three decoration sites in Great Britain, France, and Poland, respectively. As of December 2019, Stölzle-Oberglas GmbH employed over 2,800 personnel worldwide. It manufactures 3.1 billion glass containers per year and caters to the packaging glass demand from pharma, perfumery & cosmetics, spirits, and tableware markets.

  • West Pharmaceutical Services, Inc.: The company was established in 1923 and is headquartered in Pennsylvania, U.S. The company manufactures packaging components and delivery systems for injectable drugs and healthcare products. Various products offered by the company are vial containment solutions, pre-fillable systems, self-injection platforms, cartridge systems and components, reconstitution & transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing & analytical services. The key business segments of the company include proprietary products and contract-manufactured products. The company’s proprietary products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings for biologic, generic, and pharmaceutical drug customers. Its contract-manufactured products segment serves as an integrated business focused on the design, manufacture, and automated assembly of various devices, primarily for pharmaceutical, diagnostic, and medical device customers.

  • Schott AG: The company was established in 1884 and is headquartered in Mainz, Germany. The Carl Zeiss Foundation is the sole shareholder of SCHOTT AG (Mainz, Germany) and Carl Zeiss AG (Oberkochen, Germany). The company develops and manufactures special glass, specialty materials, components, and pharmaceutical systems. The company operates through seven business segments, namely advanced optics, electronic packaging, flat glass, home tech, lighting and imaging, pharmaceutical systems, and tubing. Schott AG’s pharmaceutical systems segment manufactures pharmaceutical primary packaging and provides analytical lab services. The company offers syringes, vials, ampoules, cartridges, and special articles of tubing glass or polymer. As of 2019, the company generated 45.0% of its revenue from Europe, followed by Asia (25.0%), North America (23.0%), South America (5.0%), and Rest of the World (2.0%). As of September 2019, the company operated manufacturing sites and sales offices in more than 35 countries across Europe, Asia, North America, and South America and employed over 16,200 personnel worldwide.

  • Gerresheimer AG: The company was established in 2004 and is headquartered in Düsseldorf, Germany. It operates through two business segments, namely plastics & devices, and primary packaging glass. The company’s plastics & devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syringes. Gerresheimer AG’s primary packaging glass segment focuses on the production of the packaging of glass for medicines and cosmetics, such as pharmaceutical jars, ampoules, injection vials, cartridges, perfume flacons, cream jars, and glass containers for the food & beverage industry. The company operates approximately 40 production facilities in Europe, North America, South America, and Asia. As of December 2019, the company had 9,872 employees. Pharma & healthcare application segment accounted for 81.0% of its sales generated in 2019, followed by cosmetics (13.0%), and others (6.0%). Moreover, in 2019, the plastics and devices segment accounted for 54.5% revenue share, whereas primary packaging glass accounted for 45.3% of the total revenue generated.

  • Bormioli Pharma S.r.l: is headquartered in Milano, Italy, and was founded in 2017. Since 2017, the company has operated as a portfolio company of Triton, an investment firm. Bormioli Pharma offers a wide range of glass packaging for the pharmaceutical market. Its product range includes glass and plastic vials, closure systems, containers, and accessories for antibiotics, infusions, syrups, drops, pills, and reagents. Bormioli Pharma S.r.l is certified with ISO 9001:2008 and ISO 15378. It has also been awarded certification for compliance with European Directive 93/42 EEC for medical devices. The company is registered with international control bodies such as the FDA for the United States market, TPP for Canada market, and SDA for China market. The manufacturing facilities of the company include six furnaces that manufacture both tubular and molded glass packaging products. The company caters its products to several industries in the pharmaceutical, cosmetics, and food sectors. It runs five plants specialized in the manufacturing of glass and plastic packaging. Moreover, it operates through four commercial platforms and caters to products in more than 100 countries across the globe. As of 2019, the employee strength of the company was over 950 personnel.

  • Shandong Medicinal Glass Co., Ltd.: The company was incorporated in 1970 and is headquartered in Zibo, China. The company is principally engaged in the manufacturing and distribution of pharmaceutical glass products. Its products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops, and plastic bottles. The company is one of the largest manufacturers of medicinal glass packaging products and butyl rubber plug products in Asia. The company sells its products to over 1000 medical enterprises in China and Taiwan. Moreover, the company exports to more than 65 countries including Korea, Pakistan, the U.S., Mexico, Spain, India, Philippines, Italy, Syria, Thailand, Vietnam, and the Middle East countries.

  • Beatson Clark: The company was established in 1751 and is headquartered in South Yorkshire, UK. The company was initially involved in the manufacturing of glass containers for the pharmaceutical industry, which later diversified into food & beverage markets. The company exports approximately 20% of its products in over 60 countries globally. The company produces 514 million units of pharmaceutical glass containers annually with a capacity of 145,000 tons, as of 2018. As of December 2019, the company employed 231 personnel. Newship Group, the parent company of Beatson Clark Ltd., is a privately owned group of companies operating in the packaging, construction, engineering, and event hire markets across Europe.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Pharmaceutical Glass Packaging Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2023, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Pharmaceutical Glass Packaging Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.